These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32209694)

  • 21. Characterization of the dermonecrotic toxin in members of the genus Bordetella.
    Walker KE; Weiss AA
    Infect Immun; 1994 Sep; 62(9):3817-28. PubMed ID: 8063398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Eukaryotic Host Factor 14-3-3 Inactivates Adenylate Cyclase Toxins of Bordetella bronchiseptica and B. parapertussis, but Not B. pertussis.
    Fukui-Miyazaki A; Toshima H; Hiramatsu Y; Okada K; Nakamura K; Ishigaki K; Shinzawa N; Abe H; Horiguchi Y
    mBio; 2018 Aug; 9(4):. PubMed ID: 30154257
    [No Abstract]   [Full Text] [Related]  

  • 23. Enzymatic activity of adenylate cyclase toxin from Bordetella pertussis is not required for hemolysis.
    Ehrmann IE; Weiss AA; Goodwin MS; Gray MC; Barry E; Hewlett EL
    FEBS Lett; 1992 Jun; 304(1):51-6. PubMed ID: 1319923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.
    Carbonetti NH
    Future Microbiol; 2010 Mar; 5(3):455-69. PubMed ID: 20210554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.
    Skopova K; Tomalova B; Kanchev I; Rossmann P; Svedova M; Adkins I; Bibova I; Tomala J; Masin J; Guiso N; Osicka R; Sedlacek R; Kovar M; Sebo P
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp.
    McNichol BA; Rasmussen SB; Meysick KC; O'Brien AD
    Mol Microbiol; 2006 May; 60(4):939-50. PubMed ID: 16677305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RNA chaperone Hfq is required for virulence of Bordetella pertussis.
    Bibova I; Skopova K; Masin J; Cerny O; Hot D; Sebo P; Vecerek B
    Infect Immun; 2013 Nov; 81(11):4081-90. PubMed ID: 23980112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and characterization of the dermonecrotic toxin gene of Bordetella bronchiseptica].
    Xue Y; Zhao Z; Pei J; Wang C; Ding K; Cheng X
    Sheng Wu Gong Cheng Xue Bao; 2011 Dec; 27(12):1722-8. PubMed ID: 22506412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
    DiVenere AM; Amengor D; Silva RP; Goldsmith JA; McLellan JS; Maynard JA
    mBio; 2022 Aug; 13(4):e0152722. PubMed ID: 35920558
    [No Abstract]   [Full Text] [Related]  

  • 30.
    Nash ZM; Inatsuka CS; Cotter PA; Johnson RM
    mBio; 2024 May; 15(5):e0063224. PubMed ID: 38534159
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
    Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
    Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Malandra A; Rahman WU; Klimova N; Streparola G; Holubova J; Osickova A; Bariselli S; Sebo P; Osicka R
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract.
    Carbonetti NH; Artamonova GV; Andreasen C; Bushar N
    Infect Immun; 2005 May; 73(5):2698-703. PubMed ID: 15845471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase variant of Bordetella pertussis with a mutation in a new locus involved in the regulation of pertussis toxin and adenylate cyclase toxin expression.
    Carbonetti NH; Khelef N; Guiso N; Gross R
    J Bacteriol; 1993 Oct; 175(20):6679-88. PubMed ID: 8407844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum resistance in bvg-regulated mutants of Bordetella pertussis.
    Fernandez RC; Weiss AA
    FEMS Microbiol Lett; 1998 Jun; 163(1):57-63. PubMed ID: 9631546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction.
    Zaretzky FR; Gray MC; Hewlett EL
    Mol Microbiol; 2002 Sep; 45(6):1589-98. PubMed ID: 12354227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lethal infection by Bordetella pertussis mutants in the infant mouse model.
    Weiss AA; Goodwin MS
    Infect Immun; 1989 Dec; 57(12):3757-64. PubMed ID: 2572561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.
    Gross MK; Au DC; Smith AL; Storm DR
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4898-902. PubMed ID: 1594590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bordetella dermonecrotic toxin binds to target cells via the N-terminal 30 amino acids.
    Fukui-Miyazaki A; Ohnishi S; Kamitani S; Abe H; Horiguchi Y
    Microbiol Immunol; 2011 Mar; 55(3):154-9. PubMed ID: 21204952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.
    Kerr JR; Matthews RC
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):77-88. PubMed ID: 10746492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.